These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines. Ahmed OM, Mohamed MA, Ahmed RR, Ahmed SA. Eur J Med Chem; 2009 Sep 15; 44(9):3519-23. PubMed ID: 19398146 [Abstract] [Full Text] [Related]
15. Pyrazolo[3,4-d]pyrimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR). Hubbard RD, Bamaung NY, Palazzo F, Zhang Q, Kovar P, Osterling DJ, Hu X, Wilsbacher JL, Johnson EF, Bouska J, Wang J, Bell RL, Davidsen SK, Sheppard GS. Bioorg Med Chem Lett; 2007 Oct 01; 17(19):5406-9. PubMed ID: 17689078 [Abstract] [Full Text] [Related]
16. Synthesis of 1H-pyrazolo[4,3-d]pyrimidine-7(6H)-ones and pyrazolo-5-carboxamides and interaction with benzodiazepine and adenosine A1 receptors in rat cerebral cortex. Baraldi PG, Casolari A, Manfredini S, Periotto V, Zanirato V, Florio C, Traversa V, Bertelli GM, Borea PA. Arzneimittelforschung; 1988 Sep 01; 38(9):1262-5. PubMed ID: 2852012 [Abstract] [Full Text] [Related]
17. Synthesis and anti-tumor activities of novel pyrazolo[1,5-a]pyrimidines. Li J, Zhao YF, Zhao XL, Yuan XY, Gong P. Arch Pharm (Weinheim); 2006 Nov 01; 339(11):593-7. PubMed ID: 17036367 [Abstract] [Full Text] [Related]
18. Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell lines. Manetti F, Brullo C, Magnani M, Mosci F, Chelli B, Crespan E, Schenone S, Naldini A, Bruno O, Trincavelli ML, Maga G, Carraro F, Martini C, Bondavalli F, Botta M. J Med Chem; 2008 Mar 13; 51(5):1252-9. PubMed ID: 18257513 [Abstract] [Full Text] [Related]
19. Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors. Ducray R, Ballard P, Barlaam BC, Hickinson MD, Kettle JG, Ogilvie DJ, Trigwell CB. Bioorg Med Chem Lett; 2008 Feb 01; 18(3):959-62. PubMed ID: 18182285 [Abstract] [Full Text] [Related]